38
https://pubmed.ncbi.nlm.nih.gov/38117062
A newly developed NIR-II photosensitizer, Y6-Th, shows potential for efficient diagnosis and treatment of hypoxic tumors through NIR-II fluorescence-guided type-I photodynamic/photothermal therapy.